Current treatment options in dermatofibrosarcoma protuberans

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 5, 2009, Pages 653-665

  Lemm, Doreen ^a   Mugge L O ^a   Mentzel, T ^b   Hoffken K ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

Dermatofibrosarcoma protuberans; Imatinib; Platelet derived growth factor receptor; Skin sarcoma; Surgery; Targeted therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; IMATINIB; MESNA; METHOTREXATE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; VINBLASTINE; VINCRISTINE;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CHEMOSURGERY; CHROMOSOME 17; CHROMOSOME 22; CHROMOSOME ABERRATION; CYTOGENETICS; DERMATOFIBROSARCOMA PROTUBERANS; EXCISION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; LYMPHADENECTOMY; METASTASIS; MULTIPLE CYCLE TREATMENT; PATHOGENESIS; PRIORITY JOURNAL; RECURRENCE RISK; TREATMENT DURATION;

ANTINEOPLASTIC AGENTS; CELL DIVISION; DERMATOFIBROSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSURGERY; NEOPLASM RECURRENCE, LOCAL; PIPERAZINES; PYRIMIDINES; RECURRENCE; SKIN NEOPLASMS;

EID: 63549107230     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0550-3     Document Type: Article

References (135)

1. JJ Abbott AM Oliveira AG Nascimento 2006 The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans Am J Surg Pathol 30 436 443 10.1097/00000478-200604000-00002
2. P Abenoza T Lillemoe 1993 CD34 and Factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans Am J Dermatopathol 15 429 434 10.1097/00000372-199310000-00003
3. TA Abrams SM Schuetze 2006 Targeted therapy for dermatofibrosarcoma protuberans Curr Oncol Rep 8 291 296 10.1007/s11912-006-0035-3
4. A Ah-Weng JR Marsden DS Sanders R Waters 2002 Dermatofibrosarcoma protuberans treated by Mohs micrographic surgery Br J Cancer 87 1386 1389 10.1038/sj.bjc.6600643
5. S Aiba N Tabata H Ishii 1992 Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34 Br J Dermatol 127 79 84 10.1111/j.1365-2133.1992.tb08036.x
6. MT Ballo GK Zagars P Pisters A Pollack 1998 The role of radiation therapy in the management of dermatofibrosarcoma protuberans Int J Radiat Oncol Biol Phys 40 823 827 10.1016/S0360-3016(97)00895-X
7. L Barnes JA Coleman JT Johnson 1984 Dermatofibrosarcoma protuberans of the head and neck Arch Otolaryngol 111 132 138
8. B Bednar 1957 Storiform neurofibromas of the skin, pigmented and nonpigmented Cancer 10 368 10.1002/1097-0142(195703/04)10:2<368::AID- CNCR2820100218>3.0.CO;2-3
9. R Behbahani P Patenotre N Capon 2005 Vers une réduction des marges latérales dans les dermatofibrosarcomes de Darier et Ferrand? Étude rétrospective de 34 cas Ann Chir Plast Esthet 50 179 185 10.1016/j.anplas.2005.03.006
10. WB Bowne CR Antonescu DHY Leung 2000 Dermatofibrosarcoma protuberans. A clinicopathologic analysis of patients treated and followed at a single institution Cancer 88 2711 2720 10.1002/1097-0142(20000615)88:12<2711::AID- CNCR9>3.0.CO;2-M
11. W Brenner K Schaefler H Chabra A Postel 1975 Dermatofibrosarcoma protuberans metastatic to a regional lymph node: report of a case and review Cancer 36 1897 1902 10.1002/1097-0142(197511)36:5<1897::AID- CNCR2820360547>3.0.CO;2-X
12. H Breuninger G Schaumburg-Lever 1988 Control of excisional margins by conventional histopathological techniques in the treatment of skin tumours. An alternative to Moh's technique J Pathol 154 16 71 10.1002/path.1711540209
13. H Breuninger A Thaller W Schippert 1994 Die subklinische Ausbreitung des Dermatofibrosarcoma protuberans (DFSP) und daraus resultierende Behandlungsmodalitäten Hautarzt 45 541 545 10.1007/s001050050123
14. E Buchdunger CL Cioffi N Law 2000 Abl protein-tyrosine kinase inhibitor STI 571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors J Pharmacol Exp Ther 295 139 145
15. BR Burkhardt EH Soule RK Winkelman 1966 Dermatofibrosarcoma protuberans: study of fifty-six cases Am J Surg 166 638 644 10.1016/0002-9610(66)90031-6
16. E Calonje CDM Fletcher 1996 Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: clinicopathologic analysis of 5 cases J Cutan Pathol 23 30 36 10.1111/j.1600-0560.1996.tb00774.x
17. M Chacon A Gonzalez G Urrutia 2004 Dermatofibrosarcoma protuberans (DFSP): Mohs surgery technique and prognostic factors J Clin Oncol 22 Suppl 14 9066
18. CK Chang IA Jacobs GI Salti 2004 Outcomes of surgery for dermatofibrosarcoma protuberans Eur J Surg Oncol 30 341 345 10.1016/j.ejso.2003. 12.005
19. JH Connelly HL Evans 1992 Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas Am J Surg Pathol 16 921 925 10.1097/00000478-199210000-00001
20. VD Criscione MA Weinstock 2007 Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002 J Am Acad Dermatol 56 968 973 10.1016/j.jaad.2006.09.006
21. R Dagan CG Morris Zloteki Ra 2005 Radiotherapy in the treatment of dermatofibrosarcoma protuberans Am J Clin Oncol 28 537 539 10.1097/01.coc. 0000171278.69291.64
22. F D'Andrea A Vozza S Brongo F Di Girolamo G Vozza 2001 Dermatofibrosarcoma protuberans: experience with 14 cases J Eur Acad Dermatol Venereol 15 427 429 10.1046/j.0926-9959.2001.00307.x
23. J Darier M Ferrand 1924 Dermatofibromes progressifs et recidivants ou fibrosarcomes de la peu Ann Dermatol Syphiligr (Paris) 5 542 562
24. HK Dawes CW Hanke 1996 Dermatotibrosarcoma protuberans treated with Mohs micrographic surgery-cure rates and surgical margins J Dermatol Surg Oncol 22 530 534 10.1016/1076-0512(95)00171-9
25. J Ding H Hashimoto M Enjoji 1989 Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumors Cancer 64 721 729 10.1002/1097-0142(19890801)64:3<721:: AID-CNCR2820640326>3.0.CO;2-Q
26. AH Diwan HG Skelton III MG Horenstein DR Kelly TL Barrett AH Bussian DY Sanders AJ Lazar VG Prieto KJ Smith 2008 Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity J Cutan Pathol 35 7 647 650 10.1111/j.1600-0560.2007.00872.x
27. D DuBay V Cimmino L Lowe 2004 Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution Cancer 100 1008 1016 10.1002/cncr.20051
28. WB Dupree JM Langloss SW Weiss 1985 Pigmented dermatofibrosarcoma protuberans (Bednar tumor). A pathologic, ultrastructural, and immunohistochemical study Am J Surg Pathol 9 630 639 10.1097/00000478-198509000- 00002
29. GW Elgart A Hanly M Busso JM Spencer 1999 Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy J Am Acad Dermatol 40 315 10.1016/S0190-9622(99)70474-3
30. M Fiore R Miceli C Mussi 2005 Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate J Clin Oncol 23 7669 7675 10.1200/JCO.2005.02.5122
31. CDM Fletcher JM Theaker A Flanagan T Krausz 1988 Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study Histopathology 13 631 643
32. HF Frierson PH Cooper 1983 Myxoid variant of dermatofibrosarcoma protuberans Am J Surg Pathol 7 445 450 10.1097/00000478-198307000-00007
33. C Garcia RE Clark M Buchanen 1996 Dermatofibrosarcoma protuberans Int J Dermatol 35 12 867 871 10.1111/j.1365-4362.1996.tb05053.x
34. C Garcia G Viehman M Hitchcock RE Clark 1996 Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability Dermatol Surg 22 177 179 10.1016/1076-0512(95)00499-8
35. S George GD Demetri 2007 Dermatofibrosarcoma protuberans case report: when drug therapy can obviate the need for surgery Commun Oncol 4 462 463
36. HM Gloster Jr 1996 Dermatofibrosarcoma protuberans J Am Acad Dermatol 35 355 374 10.1016/S0190-9622(96)90597-6
37. HM Gloster Jr KR Harris RK Roenigk 1996 A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans J Am Acad Dermatol 35 82 87 10.1016/S0190- 9622(96)90597-6
38. JR Goldblum JD Reith SW Weiss 2000 Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up Am J Surg Pathol 24 1125 1130 10.1097/00000478-200008000-00010
39. A Greco E Roccato C Miranda 2001 Growth-inhibitory effect of STI571 on cells transformed by the COL1A/PDGFB rearrangement Int J Cancer 92 354 360 10.1002/ijc.1190
40. DR Guillen CJ Cockerell 2001 Cutaneous and subcutaneous sarcomas Clin Dermatol 19 262 268 10.1016/S0738-081X(01)00177-8
41. RL Haas RB Keus BM Loftus 1997 The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft tissue Tumours Working Group Eur J Cancer 33 1055 1060 10.1016/S0959-8049(97)00026-9
42. Y Har-Shai J Govrin-Yehudain Y Ullmann 1993 Dermatofibrosarcoma protuberans appearing during pregnancy Ann Plast Surg 31 91 93
43. CL Haycox PB Odland SM Olbricht B Casey 1997 Dermatofibrosarcoma protuberans (DFSP): growth characteristics based on tumor modelling and a review of cases treated with Mohs micrographic surgery Ann Plast Surg 38 246 251 10.1097/00000637-199703000-00010
44. CL Haycox PB Odland SM Olbricht M Piepkorn 1997 Immunhistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment J Am Acad Dermatol 37 438 444 10.1016/S0190-9622(97) 70146-4
45. M Horta M Caetano N Rocha I Calhim V Costa A Massa 2003 Dermatofibrosarcoma protuberans. Review of 16 cases Skin Cancer 18 21 28
46. MJ Huether JA Zitelli DG Brodland 2001 Mohs micrographic surgery for the treatment of spindle cell tumors of the skin J Am Acad Dermatol 44 4 656 659 10.1067/mjd.2001.112381
47. FJ Jimenez JM Grichnik MD Buchanan RE Clark 1994 Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans J Dermatol Surg Oncol 20 687 689
48. H Joensuu PJ Roberts M Sarlomo-Rikala 2001 Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor N Engl J Med 344 1052 1056 10.1056/NEJM200104053441404
49. B Kasper D Lossignol T Gil 2006 Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp Anticancer Drugs 17 1223 1225 10.1097/01.cad.0000231486.94191.65
50. VP Khatri JM Galante RJ Bold PD Schneider R Ramsamooj JE Goodnight Jr 2003 Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment Ann Surg Oncol 10 1118 1122 10.1245/ASO.2003.03.581
51. S Kiuru-Kuhlefelt W El-Rifai J Fanburg-Smith 2001 Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans Cytogenet Cell Genet 92 192 195 10.1159/000056901
52. CK Koh CB Ko HP Bury EH Wyatt 1995 Dermatofibrosarcoma protuberans Int J Dermatol 34 256 260 10.1111/j.1365-4362.1995.tb01591.x
53. MJ Kransdorf 1995 Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex and location AJR Am J Roentgenol 164 129 134
54. GJ Kricorian CF Schanbacher AP Kelly RG Bennett 2000 Dermatofibrosarcoma protuberans growing around plantar aponeurosis: excision by Mohs micrographic surgery Dermatol Surg 26 941 945 10.1046/j.1524-4725.2000.026010941.x
55. H Kutzner 1993 Expression of the human progenitor cell antigen (CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue J Am Acad Dermatol 28 613 617
56. SV Labropoulos JA Fletcher AM Oliveira 2005 Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate Anticancer Drugs 16 461 466 10.1097/00001813-200504000-00014
57. P Lal R Sharma H Mohan MS Sekhon 1999 Dermatofibrosarcoma protuberans metastasizing to lymph nodes: a case report and review of literature J Surg Oncol 72 178 180 10.1002/(SICI)1096-9098(199911)72:3<178::AID-JSO12>3.0. CO;2-7
58. D Lemm LO Muegge K Hoeffken A Talal T Mentzel M Thorwarth S Schultze-Mosgau 2008 Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans-a case report Oral Maxillofac Surg 12 4 209 213 10.1007/s10006-008-0130-8
59. NJ Lindner MT Scarborough GJ Powell 1999 Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities Eur J Surg Oncol 25 392 397 10.1053/ejso.1999.0663
60. L Loss NC Zeitouni 2005 Management of scalp dermatofibrosarcoma protuberans Dermatol Surg 31 1428 1433
61. Macapinlac M, Elrafei T, Cunningham I, et al (2004) Dermatofibrosarcoma protuberans: neoadjuvant therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical response. J Clin Oncol 2004 ASCO annual meeting proceedings, vol 22, No. 14S (July 15 Supplement), p 9049
62. RS Macarenco R Zamolyi MF Franco AG Nascimento JJ Abott X Wang MR Erickson-Johnson AM Oliveira 2008 Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans Genes Chromosomes Cancer 47 3 260 265 10.1002/gcc.20530
63. RG Maki RA Awan RH Dixon 2002 Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans Int J Cancer 100 623 626 10.1002/ijc.10535
64. JR Marcus JW Few C Senger M Reynolds 1998 Dermatofibrosarcoma protuberans and the Bednar tumor: treatment in the pediatric population J Pediatr Surg 33 1811 1814 10.1016/S0022-3468(98)90292-5
65. RJ Mark JW Bailet LM Tran J Poen YS Fu TC Calcaterra 1993 Dermatofibrosarcoma protuberans of the head and neck. A report of 16 cases Arch Otolaryngol Head Neck Surg 119 8 891 896
66. LB Marks H Suit AE Rosenberg WC Wood 1989 Dermatofibrosarcoma protuberans treated with radiation therapy Int J Radiat Oncol Biol Phys 17 379 384
67. L Martin F Piette P Blanc L Mortier 2005 Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans Br J Dermatol 153 932 936 10.1111/j.1365-2133.2005.06823.x
68. RA Massey J Tok BA Strippoli MJ Szabolcs DN Silvers YD Eliezri 1998 A comparison of frozen and paraffin sections in dermatofibrosarcoma protuberans Dermatol Surg 24 995 998 10.1016/S1076-0512(98)00055-7
69. MJ Mauro BJ Druker 2001 STI571: targeting BCR-ABL as therapy for CML Oncologist 6 233 238 10.1634/theoncologist.6-3-233
70. ME Mavili KG Gursu A Gokoz 1994 Dermatofibrosarcoma with lymph node involvement Ann Plast Surg 32 438 440 10.1097/00000637-199404000-00022
71. GA McArthur 2006 Dermatofibrosarcoma protuberans: a surgical disease with a molecular savior Curr Opin Oncol 18 341 346 10.1097/01.cco.0000228739.62756. df
72. GA McArthur 2007 Molecular targeting of dermatofibrosarcoma protuberans: a new approach to a surgical disease J Natl Compr Canc Netw 5 5 557 562
73. GA McArthur GD Demetri A van Oosterom 2005 Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with Imatinib: Imatinib target exploration consortium study B2225 J Clin Oncol 23 866 873 10.1200/JCO.2005.07.088
74. CJ McPeak T Cruz AD Nicastri 1967 Dermatofibrosarcoma protuberans: an analysis of 86 cases-five with metastasis Ann Surg 166 803 816 10.1097/00000658-196711000-00011
75. K Mehrany NA Swanson MD Heinrich 2006 Dermatofibrosarcoma protuberans: a partial response to Imatinib therapy Dermatol Surg 32 456 459
76. WM Mendenhall RA Zlotecki MT Scarborough 2004 Dermatofibrosarcoma protuberans Cancer 101 2503 2508 10.1002/cncr.20678
77. CB Mendoza Jr WH Gerwig Jr AL Watne 1970 Dermatofibrosarcoma protuberans with metastases treated with methotrexate Am J Surg 120 119 121 10.1016/S0002-9610(70)80162-3
78. T Mentzel A Beham D Katenkamp 1998 Fibrosarcomatous ("high- grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance Am J Surg Pathol 22 576 587 10.1097/00000478-199805000-00009
79. T Mentzel L Scharer D Kazakov M Michal 2007 Myxoid Dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases Am J Dermatopathol 29 5 443 448
80. Misset J, Kerob D, Porcher R et al (2007) Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: result of a multicentric phase II study on 25 patients. J Clin Oncol 2007, ASCO annual meeting proceedings, vol 25, No 18S (June 20 Supplement), p 10032
81. K Mizutani Y Tamada K Hara 2004 Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans Br J Dermatol 151 235 236 10.1111/j.1365-2133.2004.06024.x
82. FE Mohs 1980 Chemosurgery Clin Plast Surg 7 349 360
83. R Naeem ML Lux SF Huang SP Naber JM Corson JA Fletcher 1995 Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22 Am J Pathol 147 1553 1558
84. T Nakra T Cook RS Douglas RA Goldberg 2004 Dermatofibrosarcoma protuberans metastatic to the orbit Arch Ophthalmol 122 1240 1241 10.1001/archopht.122.8.1240
85. A Ng H Nishikawa A Lander R Grundy 2005 Chemosensitivity in pediatric dermatofibrosarcoma protuberans J Pediatr Hematol Oncol 27 100 102 10.1097/01.mph.0000152861.05622.99
86. J Nishio H Iwasaki M Ishiguro 2001 Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22: a fluorescence in situ hybridization and comparative genomic hybridization analysis Genes Chromosomes Cancer 30 305 309 10.1002/1098-2264(2000)9999:9999<::AID-GCC1091>3.0.CO;2- R
87. K Nouri R Lodha G Jimenez P Robins 2002 Mohs micrographic surgery for dermatofibrosarcoma protuberans: University of Miami and NYU experience Dermatol Surg 28 1060 1064 10.1046/j.1524-4725.2002.02084.x
88. KP O'Brien E Seroussi P Dal Cin 1998 Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas Genes Chromosomes Cancer 23 187 193 10.1002/(SICI)1098-2264(199810)23:2<187::AID- GCC13>3.0.CO;2-L
89. GT Pack EJ Tabah 1951 Dermatofibrosarcoma protuberans: a report of thirty-nine cases Arch Surg 62 391 411
90. AS Pappo BN Rao A Cain 1997 Dermatofibrosarcoma protuberans: the pediatric experience at St. Jude Children's Research Hospital Pediatr Hematol Oncol 14 563 568
91. TL Parker JA Zitelli 1995 Surgical margins for excision of dermatofibrosarcoma protuberans J Am Acad Dermatol 32 233 236 10.1016/0190-9622(95)90132-9
92. LE Parlette CK Smith LM Germain 1999 Accelerated growth of dermatofibrosarcoma protuberans during pregnancy J Am Acad Dermatol 41 778 783 10.1016/S0190-9622(99)70023-X
93. KU Patel SS Szabo VS Hernandez VG Prieto LV Abruzzo AJ Lazar D López-Terrada 2008 Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays Hum Pathol 39 2 184 193 10.1016/j.humpath.2007.06.009
94. P Popov T Böhling S Asko-Seljavaara E Tukiainen 2007 Microscopic margins and results of surgery for dermatofibrosarcoma protuberans Plast Reconstr Surg 119 1779 1784 10.1097/01.prs.0000246491.79337.25
95. VE Price JA Fletcher M Zielenska 2005 Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans Pediatr Blood Cancer 44 1 5 10.1002/pbc.20249
96. B Rademaker M Angelillo HM Reiman IT Jackson 1990 Dermatofibrosarcoma protuberans: a review of 73 cases Eur J Plast Surg 13 251 255 10.1007/BF00208325
97. D Ratner CO Thomas TM Johnson 1997 Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread J Am Acad Dermatol 37 600 613 10.1016/S0190-9622(97)70179-8
98. JD Reimann CD Fletcher 2007 Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases Am J Surg Pathol 31 9 1371 1377 10.1097/PAS.0b013e31802ff7e7
99. JK Robinson 1985 Dermatofibrosarcoma protuberans resected by Mohs' surgery (chemosurgery). A five-year prospective study J Am Acad Dermatol 12 1093 1098 10.1016/S0190-9622(85)80193-6
100. DF Roses Q Valensi G LaTrenta MN Harris 1986 Surgical treatment of dermatofibrosarcoma protuberans Surg Gynecol Obstet 162 5 449 452
101. BP Rubin SM Schuetze JF Eary 2002 Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans J Clin Oncol 20 3586 3591 10.1200/JCO.2002.01. 027
102. EJ Rutgers BB Kroon CE Albus-Lutter E Gortzak 1992 Dermatofibrosarcoma protuberans: treatment and prognosis Eur J Surg Oncol 18 241 248
103. AA Sandberg JA Bridge 2003 Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma Cancer Genet Cytogenet 140 1 12 10.1016/S0165-4608(02) 00848-8
104. P Savoia M Ortoncelli P Quaglioni MG Bernengo 2006 Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study Dermatol Surg 32 1097 1102 10.1111/j.1524-4725.2006.32236.x
105. A Shimizu KP O'Brien T Sjoblom 1999 The dermatofibrosarcoma protuberans associated collagen type Ia1/plateletderived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB Cancer Res 59 3719 3723
106. MP Simon F Pedeutour N Sirvent 1997 Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma Nat Genet 15 95 98 10.1038/ng0197-95
107. N Sirvent G Maire F Pedeutour 2003 Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment Genes Chromosomes Cancer 37 1 19 10.1002/gcc.10202
108. T Sjöblom A Shimizu KP O'Brien 2001 Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist ST1571 through induction of apoptosis Cancer Res 61 5778 5783
109. MG Smola HP Soyer E Scharnagl 1991 Surgical treatment of dermatofibrosarcoma protuberans. A retrospective study of 20 cases with review of literature Eur J Surg Oncol 17 447 453
110. SN Snow EM Gordon PO Larson 2004 Dermatofibrosarcoma protuberans: a report of 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature Cancer 101 28 38 10.1002/cncr.20316
111. A Stojadinovic HM Karpoff CR Antonescu 2000 Dermatofibrosarcoma protuberans of the head and neck Ann Surg Oncol 7 696 704 10.1007/s10434-000- 0696-3
112. A Stojadinovic A Hoos HM Karpoff 2001 Soft tissue tumors of the abdominal wall. Analysis of disease patterns and treatment Arch Surg 136 70 79 10.1001/archsurg.136.1.70
113. H Suit I Spiro HJ Mankin 1996 Radiation in management of patients with dermatofibrosarcoma protuberans J Clin Oncol 14 2365 2369
114. LM Sun CJ Wang CC Huang 2000 Dermatofibrosarcoma protuberans: Treatment results of 35 cases Radiother Oncol 57 175 181 10.1016/S0167-8140(00)00228-0
115. Z Szollosi Z Nemes 2005 Transformed dermatofibrosarcoma protuberans: a clinicopathological study of eight cases J Clin Pathol 58 751 756 10.1136/jcp.2004.019349
116. T Takahira Y Oda S Tamiya 2007 Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans Mod Pathol 20 668 675 10.1038/modpathol.3800783
117. RW Taylor 1890 Sarcomatous tumors resembling in some respects keloids Arch Dermatol 8 384 387
118. HB Taylor EB Helwig 1962 Dermatofibrosarcoma protuberans: a study of 115 cases Cancer 15 717 725 10.1002/1097-0142(196207/08)15:4<717::AID- CNCR2820150405>3.0.CO;2-2
119. MJ Terrier-Lacombe L Guillou G Maire P Terrier DR Vince N de Saint Aubain Somerhausen F Collin F Pedeutour JM Coindre 2003 Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data-a study from the French Federation of Cancer Centers Sarcoma Group Am J Surg Pathol 27 1 27 39 10.1097/00000478-200301000-00004
120. SL Thornton J Reid FA Papay AT Vidimos 2005 Childhood dermatofibrosarcoma protuberans: role of preoperative imaging J Am Acad Dermatol 53 76 83 10.1016/j.jaad.2004.11.071
121. WD Tom CP Hybarger BM Rasgon 2003 Dermatofibrosarcoma protuberans of the head and neck: treatment with Mohs surgery using inverted horizontal paraffin sectioning Laryngoscope 113 1289 1293 10.1097/00005537-200308000-00004
122. S Ugurel 2007 Targeted therapy of dermatofibrosarcoma with imatinib JDDG 5 3 261 10.1111/j.1610-0387.2007.07009.x
123. Ugurel S, Utikal J, Mohr P et al (2006) Imatinib in locally advanced dermatofibrosarcoma protuberans (DFSP): a phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG). 2006 ASCO annual meeting proceedings part I, vol 24, No. 18S (June 20 Supplement), p 9561
124. S Ugurel RD Kortmann P Mohr T Mentzel C Garbe H Breuninger 2008 Short German guidelines: dermatofibrosarcoma protuberans J Dtsch Dermatol Ges 6 Suppl 1 17 18
125. E Vandeweyer A De Saint M Gebhart 2002 Dermatofibrosarcoma protuberans: how wide is wide in surgical excision? Acta Chir Belg 102 455 458
126. J Wacker B Khan-Durani W Hartschuh 2004 Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients Ann Surg Oncol 11 438 444 10.1245/ASO.2004.06.014
127. J Wang M Hisaoka S Shimajiri Y Morimitsu H Hashimoto 1999 Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffinembedded tissues Diagn Mol Pathol 8 113 119 10.1097/00019606-199909000- 00002
128. JM Weinstein BA Drolet NB Esterly M Rogers BS Bauer AM Wagner AJ Mancini 2003 Congenital dermatofibrosarcoma protuberans: variability in presentation Arch Dermatol 139 207 211 10.1001/archderm.139.2.207
129. RB West J Harvell SC Linn 2004 Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans Am J Surg Pathol 28 1063 1069 10.1097/01.pas.0000126857.86186.4c
130. GW Westermann H Buerger U Kappes 2002 Dermatofibrosarcoma protuberans with lung metastasis in a patient with progressive systemic sclerosis South Med J 95 363 365
131. TI Wright JE Petersen 2007 Treatment of recurrent dermatofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery Dermatol Surg 33 741 744 10.1111/j.1524-4725.2007.33154.x
132. U Wrotnowski PH Cooper BJ Shmookler 1988 Fibrosarcomatous change in dermatofibrosarcoma protuberans Am J Surg Pathol 12 287 293 10.1097/00000478- 198804000-00005
133. Y Yagi K Ueda S Maruyama R Noborio 2004 Bednar tumor: a report of two cases J Dermatol 31 484 487
134. Y Yokoyama Y Murakami M Sasaki 2004 Pancreatic metastasis of dermatofibrosarcoma protuberans J Gastroenterol 39 798 800 10.1007/s00535-004- 1376-z
135. B Zelger A Sidoroff U Stanzl 1994 Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison Am J Surg Pathol 18 677 686